The data on CCR9 expression in tumor cells, although scarce, allowed to demonstrate a positive correlation between CCR9 expression and the tumor ability to generate metastases in the small intestine (14–16), as well as between CCR9 over-expression and disease aggressiveness in acute and chronic T cell leukemias (14). The gene discussed is CCR9; the disease is T-cell prolymphocytic leukemia.